InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,634.58
(
0.03%
)
US TECH 100
18,960.40
(
0.16%
)
Dow Jones
41,606.18
(
-0.04%
)
Brent Oil
72.77
(
-0.75%
)
Bitcoin
60,345.20
(
0.08%
)
Post# of 253142
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 840
Posts 120456
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ThomasS post# 57063

Monday, 01/07/2008 1:31:29 AM

Monday, January 07, 2008 1:31:29 AM

Post# of 253142
>MNTA – Are you impressed by the composition of this Board?<

Impressed is an understatement. I would submit that there is not a more credentialed BoD in all of biotech.

If there is one knock on MNTA’s BoD, it’s that only four of the eleven directors are fully independent. Normally, I’d be concerned about this insofar as an insular BoD may find it hard to stand up to a CEO when a new direction—or new leadership—becomes imperative. However, in this case the CEO himself is a new kid on the block and I very much doubt the BoD would have any problem clipping his wings if need be.

Moreover, I like the fact that the BoD contains an assortment of VC’s who have serious money on the line even while no single VC comes close to having control of the company. (The largest shareholder, with a 13% stake, is Novartis.)

All told, MNTA’s BoD is about as good as it gets, IMO.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up